Ronald T. Wester
30Patents
13h-index
25Co-inventors
81Inventor score
Filing activity: Oct 23, 1987 → Jul 24, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6140343A | 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines | Chemistry; Metallurgy | 68 | Expired |
| US6147090A | 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines | Chemistry; Metallurgy | 54 | Expired |
| US6197786A | 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines | Chemistry; Metallurgy | 48 | Expired |
| US5338740A | Angiotensin II receptor antagonists | Chemistry; Metallurgy | 41 | Expired |
| US6489478B1 | 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines | Chemistry; Metallurgy | 39 | Expired |
| US6147089A | Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines | Emerging Cross-Sectional Technologies | 35 | Expired |
| US6310075A | Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines | Emerging Cross-Sectional Technologies | 26 | Expired |
| US6586448B1 | 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines | Chemistry; Metallurgy | 24 | Expired |
| US5034376A | Nor-statine and nor-cyclostatine polypeptides | Human Necessities | 22 | Expired |
| US4814342A | Nor-statine and nor-cyclostatine polypeptides | Emerging Cross-Sectional Technologies | 20 | Expired |
| US6140342A | Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines | Chemistry; Metallurgy | 19 | Expired |
| US10023571B2 | TYK2 inhibitors and uses thereof | Chemistry; Metallurgy | 14 | Active |
| US6395751B1 | 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines | Chemistry; Metallurgy | 14 | Expired |
| US6362198B1 | Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines | Chemistry; Metallurgy | 13 | Expired |
| US4935405A | Nor-statine and nor-cyclostatine polypeptides | Emerging Cross-Sectional Technologies | 12 | Expired |
| US10253046B2 | TYK2 inhibitors and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US9067948B2 | IRAK inhibitors and uses thereof | Human Necessities | 12 | Active |
| US10196390B2 | TYK2 inhibitors and uses thereof | Chemistry; Metallurgy | 9 | Active |
| US9212190B2 | IRAK inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 8 | Active |
| US6906082B2 | 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines | Chemistry; Metallurgy | 7 | Expired |
| US9630970B2 | TYK2 inhibitors and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US9340540B2 | TYK2 inhibitors and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US9751892B2 | IRAK inhibitors and uses thereof | Human Necessities | 4 | Active |
| US9175007B2 | IRAK inhibitors and uses thereof | Human Necessities | 3 | Active |
| US6974813B2 | N-[(substituted five-membered di-or triaza diunsaturated ring) carbonyl] guanidine derivatives for the treatment of ischemia | Chemistry; Metallurgy | 3 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.